Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
NCSM Transcript
NCS Multistage Holdings, Inc. (NCSM) Q1 2026 Earnings Call Transcript
Unknown4-30
The earnings call presents a mixed outlook. While there is improvement in cash flow and a positive net cash position, the decline in EBITDA and pressure on gross margins are concerning. The guidance indicates potential recovery and expansion opportunities, particularly internationally, but uncertainties remain, especially in Canada. The Q&A reveals some positive sentiment towards future projects and market expansion, yet there are constraints and risks, such as hiring challenges and macroeconomic uncertainties. These mixed signals suggest a neutral stock price movement in the short term.
NCS Multistage Holdings, Inc. (NCSM) Q4 2025 Earnings Call Transcript
Positive3-5
The earnings call indicates strong financial performance with a 13% revenue increase and improved EBITDA margins. Despite challenges, the company shows operational efficiency and a positive cash position. The Q&A section highlights promising market opportunities and successful integration of ResMetrics. The guidance remains optimistic, with growth in deepwater markets and enhanced recovery technologies. Overall, the sentiment is positive, likely leading to a stock price increase in the next two weeks.
NCS Multistage Holdings, Inc. (NCSM) Q3 2025 Earnings Call Transcript
Positive10-30
The earnings call revealed strong financial performance, with significant revenue and EBITDA growth, particularly in the U.S. market. The successful integration of ResMetrix and promising opportunities in the Middle East and North Sea further enhance prospects. Despite some concerns about Canadian rig counts, the company plans to defend margins and grow market share. Shareholder returns are supported by a positive net cash position. The Q&A session provided additional confidence in strategic execution and market expansion, justifying a positive outlook for stock price movement.
NCS Multistage Holdings, Inc. (NCSM) Q2 2025 Earnings Call Transcript
Positive8-1
The earnings call reflects strong financial performance with revenue exceeding expectations and improved EBITDA. Q2 revenue was the highest since 2019, and net income turned positive. Despite a slight decline in margins, cost management improved. The Q&A highlighted growth opportunities, particularly in Canada and international markets, and management's cautious optimism. Although there was some lack of clarity in guidance tightening, the overall sentiment is positive, supported by new customer wins and strategic focus on synergies and international expansion.
NCSM Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
